Cargando…

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience

Detalles Bibliográficos
Autores principales:	Tierney, Jayne F, Burdett, Sarah, Vale, Claire, Rydzewska, Larysa, Sydes, Matthew R, Langley, Ruth E, Kaplan, Richard S, Parmar, Mahesh KB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659313/ http://dx.doi.org/10.1186/1745-6215-16-S2-O4

Ejemplares similares

When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL
por: Vale, Claire L., et al.
Publicado: (2018)

A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials
por: Tierney, Jayne F., et al.
Publicado: (2021)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Assessing and improving the reliability of meta-analyses of hazard ratios derived from published time-to-event data
por: Tierney, Jayne, et al.
Publicado: (2013)

Analysis of survival data from trials with non-proportional hazards: an empirical comparison of methods
por: Royston, Patrick, et al.
Publicado: (2013)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Consumer involvement at the MRC Clinical Trials Unit: results of a survey
por: Vale, Claire L, et al.
Publicado: (2011)

A framework for the design and analysis of phase III randomised trials in uncommon diseases
por: Parmar, Mahesh, et al.
Publicado: (2015)

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
por: Dearnaley, David P, et al.
Publicado: (2009)

How systematic reviews and meta-analyses based on individual participant data can inform trial design and conduct
por: Tierney, Jayne, et al.
Publicado: (2013)

Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials()
por: Vale, Claire L., et al.
Publicado: (2015)

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
por: Rydzewska, Larysa H.M., et al.
Publicado: (2017)

Measuring the impact of methodological research at the medical research council clinical trials unit hub for trials methodology research
por: Brueton, Valerie, et al.
Publicado: (2013)

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2011)

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
por: Vale, Claire L, et al.
Publicado: (2016)

How individual participant data meta-analyses have influenced trial design, conduct, and analysis
por: Tierney, Jayne F., et al.
Publicado: (2015)

An ethnographic study of group decision making to understand and improve how trial steering committees contribute to trial conduct
por: Daykin, Anne, et al.
Publicado: (2013)

Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study
por: Tierney, Jayne F., et al.
Publicado: (2020)

Long-term post-trial follow-up of participants in randomised trials: lessons learned from the mrc / bhf heart protection study (HPS)
por: Aung, Theingi, et al.
Publicado: (2013)

Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration
por: Captur, Gaby, et al.
Publicado: (2014)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
por: Seymour, Matthew T, et al.
Publicado: (2011)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Strategies to reduce attrition in randomised trials
por: Brueton, Valerie, et al.
Publicado: (2011)

Sharing individual participant data: through a systematic reviewer lens
por: Rydzewska, Larysa H. M., et al.
Publicado: (2022)

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
por: Burdett, Sarah, et al.
Publicado: (2019)

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial
por: Kass-Iliyya, Antoine, et al.
Publicado: (2018)

Involving patients in optimising RCT participant information sheets and exploring patient acceptability of clinical trials
por: Realpe, Alba, et al.
Publicado: (2013)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

UCL Symposium Abstracts
Publicado: (2015)

Biomechanical Comparison of UCL Repair Using Suspensory Fixation Versus UCL Reconstruction
por: Mead, R. Nelson, et al.
Publicado: (2021)

Sharing data from clinical trials: the rationale for a controlled access approach
por: Sydes, Matthew R, et al.
Publicado: (2015)

The importance of rapport and relationship building when recruiting to clinical trials: a qualitative investigation of trial recruitment consultations in a surgical RCT
por: Constable, Lynda, et al.
Publicado: (2015)

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma: A randomized phase III Intergroup study by EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)
por: Baumert, Brigitta G., et al.
Publicado: (2016)

Comparison of Cyclic Fatigue Mechanics between UCL Repair with Internal Bracing and UCL Reconstruction
por: Jones, Christopher Michael, et al.
Publicado: (2017)

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)
por: Langley, Ruth E, et al.
Publicado: (2013)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Transnational Access to UCL, Belgium
por: Cortina, E.
Publicado: (2015)

Online teaching at CTU in Prague aka university under COVID restrictions
por: Svatos, Jakub, et al.
Publicado: (2021)

The treatment of multiple myeloma--an important MRC trial.
por: Johnson, P. W., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_234aoo0smru77ev44mvf0u02ah